Literature DB >> 12882903

Interaction of insulin and prior exercise in control of hepatic metabolism of a glucose load.

R Richard Pencek1, Freyja James, D Brooks Lacy, Kareem Jabbour, Phillip E Williams, Patrick T Fueger, David H Wasserman.   

Abstract

To determine if prior exercise enhances insulin-stimulated extraction of glucose by the liver, chronically catheterized dogs were submitted to 150 min of treadmill exercise or rest. After exercise or rest, dogs received portal glucose (18 micro mol x kg(-1) x min(-1)), peripheral somatostatin, and basal portal glucagon infusions from t = 0 to 150 min. A peripheral glucose infusion was used to clamp arterial blood glucose at 8.3 mmol/l. Insulin was infused into the portal vein to create either basal levels or mild hyperinsulinemia. Prior exercise did not increase whole-body glucose disposal in the presence of basal insulin (25.5 +/- 1.5 vs. 20.3 +/- 1.7 micro mol x kg(-1) x min(-1)), but resulted in a marked enhancement in the presence of elevated insulin (97.2 +/- 15.1 vs. 64.4 +/- 7.4 micro mol x kg(-1) x min(-1)). Prior exercise also increased net hepatic glucose uptake in the presence of both basal insulin (7.5 +/- 1.2 vs. 2.9 +/- 2.4 micro mol x kg(-1) x min(-1)) and elevated insulin (22.0 +/- 3.5 vs. 11.5 +/- 1.8 micro mol x kg(-1) x min(-1)). Likewise, net hepatic glucose fractional extraction was increased by prior exercise with both basal insulin (0.04 +/- 0.01 vs. 0.01 +/- 0.01 micro mol x kg(-1) x min(-1)) and elevated insulin (0.10 +/- 0.01 vs. 0.05 +/- 0.01). Hepatic glycogen synthesis was increased by elevated insulin, but was not enhanced by prior exercise. Although the increase in glucose extraction after exercise could be ascribed to increased insulin action, the increase in hepatic glycogen synthesis was independent of it.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882903     DOI: 10.2337/diabetes.52.8.1897

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

Review 1.  Exercise and the Regulation of Hepatic Metabolism.

Authors:  Elijah Trefts; Ashley S Williams; David H Wasserman
Journal:  Prog Mol Biol Transl Sci       Date:  2015-08-05       Impact factor: 3.622

Review 2.  Four grams of glucose.

Authors:  David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-07       Impact factor: 4.310

Review 3.  Mechanisms for greater insulin-stimulated glucose uptake in normal and insulin-resistant skeletal muscle after acute exercise.

Authors:  Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-20       Impact factor: 4.310

4.  Postexercise improvement in glucose uptake occurs concomitant with greater γ3-AMPK activation and AS160 phosphorylation in rat skeletal muscle.

Authors:  Haiyan Wang; Edward B Arias; Mark W Pataky; Laurie J Goodyear; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-21       Impact factor: 4.310

5.  Exercise-related hypoglycemia in diabetes mellitus.

Authors:  Lisa M Younk; Maia Mikeladze; Donna Tate; Stephen N Davis
Journal:  Expert Rev Endocrinol Metab       Date:  2011-01-01

Review 6.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 7.  New treatments for nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison
Journal:  Curr Gastroenterol Rep       Date:  2006-02

8.  Enhanced skeletal muscle insulin sensitivity after acute resistance-type exercise is upregulated by rapamycin-sensitive mTOR complex 1 inhibition.

Authors:  Kohei Kido; Kohei Sase; Takumi Yokokawa; Satoshi Fujita
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

9.  Exercise effects on γ3-AMPK activity, phosphorylation of Akt2 and AS160, and insulin-stimulated glucose uptake in insulin-resistant rat skeletal muscle.

Authors:  Mark W Pataky; Edward B Arias; Haiyan Wang; Xiaohua Zheng; Gregory D Cartee
Journal:  J Appl Physiol (1985)       Date:  2020-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.